[Drug approval: Axicabtagene ciloleucel (CAR-T cells) in diffuse large B cell lymphoma after one prior line of therapy].
Resource Type
Editorial & Opinion
Authors
Messéant O; CHU Pontchaillou, service d'hématologie clinique, 35033 Rennes cedex 09, France.; Manson G; CHU Pontchaillou, service d'hématologie clinique, 35033 Rennes cedex 09, France. Electronic address: guillaume.manson@chu-rennes.fr.
Source
Publisher: Elsevier Country of Publication: France NLM ID: 0072416 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1769-6917 (Electronic) Linking ISSN: 00074551 NLM ISO Abbreviation: Bull Cancer Subsets: MEDLINE